BCPC (Balchem) NonCurrent Deferred Liabilities: $53 Mil (As of Mar. 2026)


BCPC Balchem Corp BCPC
94 GF Score
Price $169.81
GF Value $177.28
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Balchem NonCurrent Deferred Liabilities?

Balchem BCPC +0.48% 94 NonCurrent Deferred Liabilities is $53 Mil as of Mar. 2026. GuruFocus rates BCPC with a GF Score™ of 94/100 and a GF Value™ of $177.28 (Fairly Valued). The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Balchem's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $53 Mil.

Balchem NonCurrent Deferred Liabilities Related Terms

Balchem NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Balchem's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balchem NonCurrent Deferred Liabilities Chart

Balchem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.46 62.78 52.05 43.72 54.14

Balchem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.22 47.77 47.60 54.14 53.38
BCPC
94GF Score
Balchem Corp BCPC
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $53 Mil mean?
Balchem (BCPC) has a NonCurrent Deferred Liabilities of $53 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Balchem and its competitors.
Is Balchem's NonCurrent Deferred Liabilities too high?
Balchem's current NonCurrent Deferred Liabilities is $53 Mil. Overall, Balchem has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's NonCurrent Deferred Liabilities compare to PRM and SXT?
Balchem's NonCurrent Deferred Liabilities of $53 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Chemicals company?
A good NonCurrent Deferred Liabilities depends on the Chemicals industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Balchem and its competitors. Balchem's current NonCurrent Deferred Liabilities is $53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (BCPC) is currently considered Fairly Valued. The stock's GF Value™ is $177.28, compared to a current price of $169.81 — trading 4.2% below its estimated fair value. The current NonCurrent Deferred Liabilities is $53 Mil. Balchem's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Balchem (BCPC), the current NonCurrent Deferred Liabilities is $53 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Balchem (BCPC) Overvalued in 2026?

Based on GuruFocus' analysis, Balchem stock appears to be undervalued. The current stock price of $169.81 is trading 4.2% below its estimated GF Value™ of $177.28. GuruFocus considers Balchem to be Fairly Valued.

Key valuation signals for BCPC:

  • NonCurrent Deferred Liabilities: $53 Mil
  • GF Value™: $177.28 vs. price of $169.81 (4.2% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the BCPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Balchem Business Description

Other Exchanges BL9B:Germany
Address 5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
94GF Score

Get the complete analysis for BCPC

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$169.81
Price
$177.28
GF Value